Logo image of DNTH

DIANTHUS THERAPEUTICS INC (DNTH) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:DNTH - US2528281080 - Common Stock

43.3 USD
-0.28 (-0.64%)
Last: 12/10/2025, 1:16:43 PM
Buy % Consensus

88

ChartMill assigns a Buy % Consensus number of 88% to DNTH. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 68.77. This target is 58.81% above the current price.
DNTH was analyzed by 21 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about DNTH.
In the previous month the buy percentage consensus was at a similar level.
DNTH was analyzed by 21 analysts, which is quite many. So the average rating should be quite meaningful.
DNTH Historical Analyst RatingsDNTH Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -37 -33 -29 -25 -21 -17 -13 -9 -5 -1 5 10 15 20

Price Target & Forecast

Price Low Median Mean High 43.3046.4666.3068.77105.00 - 7.30% 53.12% 58.81% 142.49%
DNTH Current Analyst RatingDNTH Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10
Up and Down Grades
Date Firm Action Rating
2025-11-10 HC Wainwright & Co. Maintains Buy -> Buy
2025-11-06 Wedbush Maintains Outperform -> Outperform
2025-10-14 Truist Securities Initiate Buy
2025-09-17 Clear Street Initiate Buy
2025-09-12 Stifel Maintains Buy -> Buy
2025-09-12 Wedbush Maintains Outperform -> Outperform
2025-09-09 Guggenheim Maintains Buy -> Buy
2025-09-09 Raymond James Reiterate Outperform -> Outperform
2025-09-09 Baird Maintains Outperform -> Outperform
2025-09-08 HC Wainwright & Co. Reiterate Buy -> Buy
2025-08-21 Wedbush Maintains Outperform -> Outperform
2025-07-02 William Blair Initiate Outperform
2025-05-13 Baird Maintains Outperform -> Outperform
2025-05-13 HC Wainwright & Co. Reiterate Buy -> Buy
2025-03-12 Guggenheim Reiterate Buy -> Buy
2025-03-12 Wedbush Reiterate Outperform -> Outperform
2025-03-12 HC Wainwright & Co. Reiterate Buy -> Buy
2024-12-20 TD Cowen Initiate Buy
2024-11-11 Oppenheimer Maintains Outperform -> Outperform
2024-11-11 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-08 Raymond James Maintains Outperform -> Outperform
2024-10-03 Oppenheimer Initiate Outperform
2024-09-26 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-12 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-09 Wedbush Maintains Outperform -> Outperform
2024-07-26 Baird Initiate Outperform
2024-06-27 Cantor Fitzgerald Initiate Overweight
2024-05-16 HC Wainwright & Co. Initiate Buy
2024-05-10 Wedbush Maintains Outperform -> Outperform
2024-04-18 Raymond James Maintains Outperform -> Outperform

DIANTHUS THERAPEUTICS INC / DNTH FAQ

Can you provide the average price target for DIANTHUS THERAPEUTICS INC stock?

21 analysts have analysed DNTH and the average price target is 68.77 USD. This implies a price increase of 58.81% is expected in the next year compared to the current price of 43.3.


How do analysts rate DIANTHUS THERAPEUTICS INC (DNTH)?

The consensus rating for DIANTHUS THERAPEUTICS INC (DNTH) is 87.619 / 100 . This indicates that analysts generally have a positive outlook on the stock.